PolyPid (PYPD) Tax Provisions (2022 - 2025)
PolyPid (PYPD) posted Tax Provisions of -$81000.0 for Q4 2025, down 468.18% sequentially from $22000.0 in Q3 2025, and down 723.08% YoY from $13000.0 in Q4 2024.
PolyPid (PYPD) Tax Provisions (2022 - 2025) Analysis & Trends
PolyPid has reported Tax Provisions for 4 years, with the latest figure at -$81000.0 in Q4 2025.
- Quarterly Tax Provisions fell 723.08% year-over-year to -$81000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 88.1% YoY) and the FY2025 annual result came in at $5000.0, down 88.1% from the prior year.
- Tax Provisions slipped to -$81000.0 in Q4 2025 per PYPD's latest filing, from $22000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $74000.0 in Q3 2022 and troughed at -$81000.0 in Q4 2025.
- A 4-year average of $17500.0 and a median of $16500.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 2550.0% in 2025, down 723.08% in 2025.
- Over 4 years, Tax Provisions stood at $55000.0 in 2022, then plunged by 83.64% to $9000.0 in 2023, then surged by 44.44% to $13000.0 in 2024, then plunged by 723.08% to -$81000.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$81000.0, $22000.0, and $53000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | PolyPid | 113.30 Mn | 106.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -81,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 74,000.00 |